Conference abstractPublished 6 Nov 2017

Role of the human cytomegalovirus in systemic sclerosis

Authors: Gnaneshwer Jadav

University of Verona, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Systemic sclerosis (SSc) is a chronic systemic inflammatory disease, characterized by vascular dysfunction, immune alteration and tissue fibrosis. Recent data suggests that patients with other autoimmune diseases have shown an expansion of unusual T-Cell population identified as CD4+/CD8+CD28- T-cells. CD4+/CD8+CD28- T-cells represent an aggressive T-Cell subset that differs from conventional CD4+/CD8+CD28 T-helpers in both phenotype and function. CD4+/CD8+CD28- T-Cell have pro-inflammatory functions and releases high number of cytotoxic enzymes. Chronic antigenic stimulation results into the aggregation of late differentiated, antigenic specific, oligoclonal T-Cell, particularly within the CD4+/CD8+ T-Cells compartments. They are characterized by loss of CD28 co-stimulatory receptors and /or gain of CD57 expression. It is interesting to see how this T cell subsets are expanded during the infection of human cytomegalovirus (HCMV). Regulatory T (Treg) believed to be converted into pathogenic cells and produces higher number of inflammatory cytokines thought to be a crucial step in the progression of many autoimmune diseases but whether loss of normal Treg cell function contributes to SSc is unknown. By considering the role of the different T cell subsets, we have aimed to evaluate the percentage of the CD4+/ CD8+CD28- T-cell, Treg cells and CD57+ CD4+/CD8+CD28- T-cell to understand whether the percentage of these T-cell subpopulations correlates with anti-HCMV antibodies and with treatment. In other autoimmune pathologies these cells are responsible for the production of proinflammatory cytokines and cytotoxic enzymes, so it would be interesting to clarify their role in scleroderma and to evaluate possible correlation with the presence of previous HCMV infection. The percentage of Treg cells does not seem to be different between patients and healthy controls.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Gnaneshwer Jadav”